** Healthcare services co Healius HLS.AX announces high single-digit EBIT margin target for FY27, exceeding estimates of Citi and Jefferies
** Market might maintain healthy level of scepticism about this target given previous false starts and valuation that is still relatively high, Citi says
** Jefferies notes potential for significant EBIT uplift, but says it will update its forecasts in line with delivery of these targets
** Jefferies also sees green shoots in Australian healthcare services and hopes HLS can benefit from this
** Citi maintains its target price at A$1.05 and rating at "neutral"; Jefferies raises target price from A$1.45 to A$1.65, keep "hold" rating
** Stock up 5.8% YTD
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。